The effect of cigarette smoke on aryl hydrocarbon hydroxylase activity and cytochrome P450 content in rat liver and lung microsomes

Effects of tobacco smoking and nicotine on cancer treatment

A substantial number of the world's population continues to smoke tobacco, even in the setting of a cancer diagnosis. Studies have shown that patients with cancer who have a history of smoking have a worse prognosis than nonsmokers. Modulation of several physiologic processes involved in drug disposition has been associated with long-term exposure to tobacco smoke. The most common of these processes can be categorized into the effects of smoking on cytochrome P450-mediated metabolism, glucuronidation, and protein binding. Perturbation in the pharmacokinetics of anticancer drugs could result in clinically significant consequences, as these drugs are among the most toxic, but potentially beneficial, pharmaceuticals prescribed. Unfortunately, the effect of tobacco smoking on drug disposition has been explored for only a few marketed anticancer drugs; thus, little prescribing information is available to guide clinicians on the vast majority of these agents. The carcinogenic properties of several compounds found in tobacco smoke have been well studied; however, relatively little attention has been given to the effects of nicotine itself on cancer growth. Data that identify nicotine's effect on cancer cell apoptosis, tumor angiogenesis, invasion, and metastasis are emerging. The implications of these data are still unclear but may lead to important questions regarding approaches to smoking cessation in patients with cancer.

Protective antioxidant mechanisms in rat and guinea pig tissues challenged by acute exposure to cigarette smoke

Cellular damage from reactive intermediates formed during xenobiotic biotransformation is prevented by the presence of adequate levels of antioxidant chemicals in the tissues. Equally important for cell protection is the rate at which these chemicals are replaced if tissue stores are depleted. The present experiments, using adult male Sprague-Dawley rats and Hartley guinea pigs, were conducted to ascertain what effects mainstream (MS) and sidestream (SS) tobacco smoke would have on the water-soluble, cytoplasmic antioxidants, ascorbic acid (AA) and reduced glutathione (GSH). The animals were exposed by nose-only inhalation to varying doses (40, 120, 240 puffs) of a 1:5 dilution of a 35-ml volume of freshly generated MS from cigarettes made from different types of tobacco and delivered by a B.-A.T-Mason inhalation apparatus. The animals were euthanized either immediately following exposure or at 3 and 6 h. The blood, lungs, liver, kidneys, heart and bladder were removed for the quantitation of AA and GSH following homogenization and deproteinization. Immediately following exposure to MS, dose-dependent decreases in pulmonary and renal GSH were observed in rats whereas, in guinea pigs, reductions in pulmonary, hepatic and renal GSH were observed only at the highest level of exposure. No reductions in tissue AA were observed in either species at any exposure level. In both species, blood levels of GSH and AA remained unchanged following exposure. Mainstream smoke (240 puffs) from flue-cured or dark, air-cured tobaccos elicited a significant, immediate reduction in pulmonary and renal GSH, but MS from low tar, filter cigarettes was without effect. Within 3 h of exposure, GSH in all tissues has returned to pre-exposure levels. Whole-body, chamber exposure to concentrated SS, generated from smouldering cigarettes, caused a dose-dependent reduction in rat pulmonary, hepatic, renal, cardiac and bladder muscle GSH but only affected pulmonary GSH in the guinea pig. Lesser effects were observed in tissues of rats exposed to diluted SS. In the rat, a comparison of the results of diethylmaleate- and smoke-induced depletion of tissue GSH suggested that, even at exceptionally high levels of exposure, there was a significant store of GSH in tissues that did not interact with tobacco smoke.

The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats

The effect of a single treatment with cigarette smoke on the blood levels and hemodynamic effects of propranolol in rats was studied. Pentobarbital sleep time was not affected whereas zoxazolamine paralysis time was shortened 72% in rats, 24 h after the cigarette smoke exposure. The beta-adrenoceptor blocking effect of propranolol observed at 10 and 20 min time intervals was abolished in rats exposed to cigarette smoke 24 h after the exposure. The blood propranolol concentrations were decreased in rats pretreated with phenobarbital, 3,4-benzpyrene and ethanol as well as in cigarette smoke exposed rats. Among several factors that could influence propranolol metabolism, in this study, enzyme induction is suggested to be dominant.

Effect of cigarette smoking on hepatic biotransformations in rats

Adult male rats were nose-only exposed to cigarette smoke for 20 min each day for 6 months. Smoke inhalation was confirmed by urinary excretion of nicotine (4.5 micrograms/rat/day) and elevated blood carboxyhemoglobin (13.3%). Phenobarbital- and 3-methylcholanthrene-treated rats were included as positive controls for assessing hepatic enzyme induction. Cigarette smoke did not induce statistically significant alterations in hepatic enzyme activity when measured in vivo (pentobarbital sleep time and zoxazolamine paralysis time) or in vitro (oxidation, hydrolysis, glucuronidation, and glutathione conjugation). In some cases, the smoke-exposed rats did exhibit higher microsomal enzyme activity than did the controls, but this increase was also evident in the sham-control group. Therefore, these increases were attributed to stress and not to smoking per se. Additional evidence of stress associated with manipulation of the animals was the smaller percentage weight gains of the smoke-exposed and sham control rats over the 6-month period as compared to the controls (12, 35, and 50%, respectively). Smoking reduced hepatic glutathione by as much as 15%, but the glutathione transferase activity was not affected. These studies showed that chronic exposure of rats to cigarette smoke did not alter hepatic biotransformation processes, but do suggest that smokers may be less efficient than nonsmokers in the deactivation of xenobiotics by glutathione conjugation mechanisms.